Application of new approach methodologies for nonclinical safety assessment of drug candidates
M
Mario Beilmann
K
Karissa Adkins
H
Harrie C. M. Boonen
P
Philip Hewitt
W
Wenyue Hu
R
Robert Mader
S
Susanne Moore
P
Payal Rana
T
Thomas Steger-Hartmann
R
Remi Villenave
T
Terry van Vleet
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 9
Published
September 01, 2025
Pages
705-725
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (11)
M
Mario Beilmann
K
Karissa Adkins
H
Harrie C. M. Boonen
P
Philip Hewitt
W
Wenyue Hu
R
Robert Mader
S
Susanne Moore
P
Payal Rana
T
Thomas Steger-Hartmann
R
Remi Villenave
T
Terry van Vleet
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w